These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21482037)

  • 41. [Effect of retroperitoneal lymphadenectomy on survival of patients with epithelial ovarian cancer].
    Xiong ZF; Wang ZH; Wang SX
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):77-80. PubMed ID: 12783692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
    Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA
    Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Validity of complete paraaortic and pelvic lymphadenectomy in apparent stage I (T1) epithelial ovarian carcinoma].
    Shimizu Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():570-7. PubMed ID: 15535310
    [No Abstract]   [Full Text] [Related]  

  • 44. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
    Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
    Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved.
    Chambers SK
    J Natl Cancer Inst; 2005 Apr; 97(8):548-9. PubMed ID: 15840870
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lymphatic metastasis of ovarian cancer and extraction of retroperitoneal lymphadenectomy].
    Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1992 Jul; 27(4):245-8. PubMed ID: 1291223
    [No Abstract]   [Full Text] [Related]  

  • 48. Surgical treatment of early ovarian cancer with compartmental resection of regional lymphatic network and indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, paraaortic part).
    Kimmig R; Buderath P; Mach P; Rusch P; Aktas B
    J Gynecol Oncol; 2017 May; 28(3):e41. PubMed ID: 28382801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?
    Sakai K; Kajiyama H; Umezu T; Shibata K; Mizuno M; Suzuki S; Kawai M; Nagasaka T; Kikkawa F
    J Obstet Gynaecol Res; 2012 Jul; 38(7):1018-23. PubMed ID: 22568659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Itamochi H; Terakawa N
    Eur J Surg Oncol; 1993 Jun; 19(3):273-8. PubMed ID: 8314386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival.
    Scarabelli C; Gallo A; Zarrelli A; Visentin C; Campagnutta E
    Gynecol Oncol; 1995 Mar; 56(3):328-37. PubMed ID: 7705665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy.
    Wu PC; Qu JY; Lang JH; Huang RL; Tang MY; Lian LJ
    Am J Obstet Gynecol; 1986 Nov; 155(5):1103-8. PubMed ID: 3777055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer--therapeutic advance or surgical folly?
    Hacker NF
    Gynecol Oncol; 1995 Mar; 56(3):325-7. PubMed ID: 7705664
    [No Abstract]   [Full Text] [Related]  

  • 55. [Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].
    Xie R; Lin YZ; Chen GL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):499-501. PubMed ID: 15555344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
    Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
    Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laparoscopic ways of para-aortic lymphadenectomy].
    Estrade JP; Lazard A; Gurriet B; Agostini A; Blanc B
    Gynecol Obstet Fertil; 2010 Feb; 38(2):135-41. PubMed ID: 20122863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.
    Yokoyama Y; Sakamoto T; Sato S; Saito Y
    Eur J Gynaecol Oncol; 1999; 20(5-6):361-6. PubMed ID: 10609495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.